Neurology® Podcast

1) Course of psychiatric symptoms and global cognition in early Parkinson disease and 2) Topic of the month: Management of sports concussion. This podcast for the Neurology Journal begins and closes with Dr. Ted Burns, Section Editor Podcasts, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Matt Barrett interviews Dr. Dan Weintraub about his paper on the course of psychiatric symptoms and global cognition in early Parkinson disease. Dr. James Addington is reading our e-Pearl of the week about KCNQ2 in early onset epileptic encephalopathy. In the next part of the podcast Dr. Stephen Donahue interviews Dr. Michael Jaffee about the management of concussion after the diagnosis has been made and the recommendation for graduated return to play or normal activities. The participants had nothing to disclose except Drs. Barrett, Weintraub, Addington and Jaffee.Dr. Barrett receives research support from the Virginia Center of Alzheimer's and Related Diseases Research Award Fund.Dr. Weintraub serves as an editorial board member of Movement Disorders Journal and Journal of Parkinson's disease; serves on the scientific advisory boards of Pfizer Inc, Teva Pharmaceuticals Industries Ltd., Avanir Pharmaceuticals, Merck Serono, Lundbeck Inc., UCB, Bristol-Myers Squibb, Novartis, Clintrex, Theravance, Medication Non-profit-CHDI, ADCS; receives license fee payments from the University of Pennsylvania for licensing of questionnaire for impulsive-compulsive disorders in Parkinson disease and QUIP and QUIP-RS; gave expert testimony for defense in two lawsuits related to impulse control disorders in Parkinson disease; receives research support from Michael J. Fox Foundation, Department of Veterans Affairs, Novartis and the NIH.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Jaffee serves on the scientific advisory boards for WETA (Public Television) Brainline, U. S. Army Peer Review Alzheimer Research Program and the NIH translational research outcome consortium review.

1) Mirror therapy in unilateral neglect after stroke and 2) Topic of the month: Management of sports concussion. This podcast for the Neurology Journal begins and closes with Dr. Ted Burns, Section Editor Podcasts, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Andy Southerland interviews Dr. Jeyaraj Pandian about his paper on mirror therapy in unilateral neglect after stroke. Dr. James Addington is reading our e-Pearl of the week about basilar-type migraine. In the next part of the podcast Dr. Stephen Donahue interviews Dr. Michael Jaffee about the acute diagnosis and management of concussion. The participants had nothing to disclose except Drs. Southerland, Pandian, Addington and Jaffee.Dr. Southerland serves as Podcast Deputy Editor for Neurology®; serves as Clinical Research Advisor for Totier Technologies, Inc.Dr. Pandian serves as Editor-in-Chief of CHRISMED J Health and Research; serves on the scientific advisory board of International J Stroke and serves as an Associate Editor for the Neurology India Journal.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Jaffee serves on the scientific advisory boards for WETA (Public Television) Brainline, U. S. Army Peer Review Alzheimer Research Program and the NIH translational research outcome consortium review.

1) Current practices in feeding tube placement for US acute ischemic stroke inpatients and 2) Topic of the month: Management of sports concussion. This podcast for the Neurology Journal begins and closes with Dr. Ted Burns, Section Editor Podcasts, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Kevin Barrett interviews Drs. Ben George and Adam Kelly about their paper on current practices in feeding tube placement for US acute ischemic stroke inpatients. Dr. James Addington is reading our e-Pearl of the week about childhood stroke: think metabolic. In the next part of the podcast Dr. Stephen Donahue interviews Dr. Michael Jaffee about the definition of concussion and how the grading has evolved over recent years. The participants had nothing to disclose except Drs. Barrett, George, Kelly, Addington and Jaffee.Dr. Barrett serves as an editorial board member of Neurology; serves as an Associate Editor of Neurohospitalist and receives research support from the NIH.Dr. George receives research support from the American Heart Association/American Stroke Association and the Parkinson's disease Foundation.Dr. Kelly serves as an editorial board member of Continuum; serves as Guest Editor for Cerebrovascular Disease issue, April 2014 and received research support from the Donald W. Reynolds Foundation.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Jaffee serves on the scientific advisory boards for WETA (Public Television) Brainline, U. S. Army Peer Review Alzheimer Research Program and the NIH translational research outcome consortium review.

Area of functional symptoms & conversion disorders. Lesson of the Week interviews from November 2013.

1) Growth hormone treatment for childhood short stature and risk of stroke in early adulthood and 2) Topic of the month: Contemporary alternative medicine therapies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Cyrus Boelman interviews Dr. Emmanuel Touze about his paper on growth hormone treatment for childhood short stature and risk of stroke in early childhood. Dr. Adam Numis is reading our e-Pearl of the week about LG-1 antibodies in limbic encephalitis. In the next part of the podcast Dr. Rebecca Wells interviews Dr. Don Levy about approaches of Integrative Medicine practitioners to patient care. The participants had nothing to disclose except Dr. Numis.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

1) A clinical pathologic study of depressive symptoms and cognitive decline in old age and 2) Topic of the month: Contemporary alternative medicine therapies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeff Burns interviews Dr. Robert S. Wilson about his paper on depressive symptoms and cognitive decline in old age. Dr. Adam Numis is reading our e-Pearl of the week about ictal syncope. In the next part of the podcast Dr. Rebecca Wells interviews Dr. Tieraona Low Dog about complementary alternative medicine therapies using supplements for treatment of headaches. The participants had nothing to disclose except Drs. Burns, Wilson and Numis. Dr. Jeff Burns serves on the editorial board for Journal of Alzheimer's Disease; receives royalties for the publications of Early diagnosis and treatment of mild cognitive impairment and Dementia: An atlas of investigation and diagnosis; is a consultant for PRA International and receives research support from the NIH, Alzheimer's Drug Discovery Foundation, Elan, Janssen Pharmaceuticals Inc., Wyeth, Pfizer Inc, Novartis Pharmaceuticals Ltd, Danone, Avid Radiopharmaceuticals, Merck Serono and for clinical trials. Dr. Wilson serves as a Consulting Editor of Aging, Neuropsychology and Cognition, Psychology and Aging, and Neuropsychology; is a consultant for Pain Therapeutics, Inc.; and receives research support from the NIH. Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section.

1) Untreated brain arteriovenous malformations: Patient level meta-analysis of hemorrhage predictors and 2) Topic of the month: Contemporary alternative medicine therapies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jeremy Lanford interviews Dr. Helen Kim about her paper on untreated brain arteriovenous malformations. Dr. Adam Numis is reading our e-Pearl of the week about spinal epidural abscesses. In the next part of the podcast Dr. Rebecca Wells interviews Dr. Remy Coeytaux about complementary alternative medicine to chronic pain and integrative medicine approaches. The participants had nothing to disclose except Drs. Coeytaux and Numis.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Coeytaux is a consultant for Samueli Institute and receives research support from the NIH.

1) Palliative care and neurology: Time for a paradigm shift and 2) Topic of the month: Contemporary alternative medicine therapies. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Alex Bragg interviews Dr. Benzi Kluger about his paper on palliative care and neurology: Time for a paradigm shift. Dr. Adam Numis is reading our e-Pearl of the week about intravascular B-cell lymphoma. In the next part of the podcast Dr. Rebecca Wells interviews Dr. Pushpa Narayanaswami about complementary alternative medicine therapies for patients with multiple sclerosis. The participants had nothing to disclose except Drs. Kluger, Numis, and Narayanaswami.Dr. Kluger serves as an editorial board member of Frontiers in Movement Disorders; received speaker honoraria from Teva Pharmaceutical Industrials Ltd., Parkinson's Association of the Rockies and National Parkinson's Foundation; receives research support from the US Army Research Laboratory and US Army Research Office, Veterans Affairs Medical Center CRICC Program, Michael J. Fox Foundation, University of Colorado Hospital Clinical Effectiveness and Patient Safety Program and the NIH.Dr. Numis serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Narayanaswami serves as an editorial board member of Neurology® Level of Evidence Review Team; is a consultant for Blue Cross Blue Shield of Massachusetts, Pharmacy and Therapeutics Committee, Advanced Medical and Boston Clinical Research Institute; performs EMG in her clinical practice (35% effort); receives research support from Merz Pharmaceuticals, Inc., Solstice Pharma and AHRQ; received research support from the NIH.

Viral meningoencephalitides, lyme disease, & bacterial meningoencephalitides. Lesson of the week interviews from June 2014.

1) Evaluation and construction of diagnostic criteria for inclusion body myositis and 2) Topic of the month: Plenary sessions AAN Meeting April 2014. This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Steven A. Greenberg about his paper on evaluation and construction of diagnostic criteria for inclusion body myositis. Dr. James Addington is reading our e-Pearl of the week about Rapid-Onset Dystonia Parkinsonism. In the next part of the podcast Dr. Alberto Espay continues his interview with Dr. Jon Stone including questions about his Contemporary Clinical Issues Lecture about functional (psychogenic) disorders in neurology from the audience at Interview Central and his responses. The participants had nothing to disclose except Drs. Burns, Greenberg, Addington, Espay and Stone.Dr. Burns serves as Podcast Editor for Neurology®; and has received research support for consulting activities with CSL Behring and Alexion Pharmaceuticals, Inc.Dr. Greenberg is a consultant for MedImmune, aTyr Pharma; receives publishing royalties from the publication of the book EMG Pearls; receives license fee payments from Composition and Methods for Diagnosing and Assessing Inflammatory Myopathies, MedImmune; receives revenue for patents for composition and methods for diagnosing and assessing inflammatory myopathies, detecting inclusion body myositis; receives research support from MedImmune, Novartis and the NIH; serves on the scientific advisory board for MedImmune; received funding for travel from Biogen Idec and Genzyme Corporation.Dr. Addington serves on the editorial team for the Neurology® Resident and Fellow Section. Dr. Espay serves as an Associate Editor of Movement Disorders, Frontiers in Movement Disorders and Journal of Clinical Movement Disorders; serves as an editorial board member of Parkinsonism and Related Disorders and The European Neurological Journal; receives royalties for publications of books from Lippincott, Williams & Wilkins and from Cambridge University Press; serves on the scientific advisory board for Solvay Pharmaceuticals, Inc. (now Abbvie), Chelsea Therapeutics, Teva Pharmaceutical Industries Ltd., Impax Pharmaceuticals, Merz, Pfizer Inc, Solstice Neurosciences, LLC, Eli Lilly and Company, US WorldMeds; is a consultant for Chelsea Therapeutics, Solvay Pharmaceuticals, Inc. (now Abbvie); serves on the speakers' bureaus of Novartis, UCB, Teva Pharmaceutical Industries Ltd., American Academy of Neurology, Movement Disorders Society; receives research support from CleveMed/Great Lakes Neurotechnologies, Michael J. Fox Foundation and the NIH.Dr. Stone received speaker honoraria from the Movement Disorders Society, British Medical Association, American Academy of Neurology Royal College of Psychiatrists, UCB Pharma, Novartis, Tribunals Judiciary (UK); receives research support from the National Research Strategy Career Fellow with NHS Scotland Research; receives publishing royalties from UptoDate 2014; runs a free self-help website for patients with functional disorders www.neurosymptoms.org; carries out regular expert witness work in relation to personal injury and medical negligence.